SYROS PHARMACEUTICALS, INC. Retained Earnings
SYROS PHARMACEUTICALS, INC. had Retained Earnings of -$756.24 million as of 2024-09-30, per its 10-Q filed 2024-10-31.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2024-10-31
- 2024-09-30: Retained Earnings (Accumulated Deficit) -$756.24M.
- 2024-06-30: Retained Earnings (Accumulated Deficit) -$749.84M.
- 2024-03-31: Retained Earnings (Accumulated Deficit) -$726.51M.
- 2023-12-31: Retained Earnings (Accumulated Deficit) -$722.81M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2024-09-30 | -$756.24M 10-Q · filed 2024-10-31 |
| 2024-06-30 | -$749.84M 10-Q · filed 2024-07-31 |
| 2024-03-31 | -$726.51M 10-Q · filed 2024-05-14 |
| 2023-12-31 | -$722.81M 10-Q · filed 2024-10-31 |
| 2023-09-30 | -$658.42M 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$618.28M 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$582.02M 10-Q · filed 2023-05-10 |
| 2022-12-31 | -$558.23M 10-K · filed 2024-03-27 |
| 2022-09-30 | -$553.46M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$523.21M 10-Q · filed 2022-08-09 |
| 2022-03-31 | -$488.73M 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$463.58M 10-K · filed 2023-03-02 |
| 2021-09-30 | -$439.77M 10-Q · filed 2021-11-05 |
| 2021-06-30 | -$413.74M 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$391.25M 10-Q · filed 2021-05-06 |
| 2020-12-31 | -$377.02M 10-K · filed 2022-03-15 |
| 2020-09-30 | -$346.89M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$327.40M 10-Q · filed 2020-08-06 |
| 2020-03-31 | -$310.21M 10-Q · filed 2020-05-07 |
| 2019-12-31 | -$292.98M 10-K · filed 2021-03-04 |
| 2019-09-30 | -$273.25M 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$253.46M 10-Q · filed 2019-08-01 |
| 2019-03-31 | -$234.01M 10-Q · filed 2019-05-01 |
| 2018-12-31 | -$217.54M 10-K · filed 2020-03-05 |
| 2018-09-30 | -$199.51M 10-Q · filed 2018-11-01 |
| 2018-06-30 | -$183.78M 10-Q · filed 2018-08-07 |
| 2018-03-31 | -$169.73M 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$155.27M 10-K · filed 2019-03-07 |
| 2017-09-30 | -$139.96M 10-Q · filed 2017-11-08 |
| 2017-06-30 | -$126.14M 10-Q · filed 2017-08-09 |
| 2017-03-31 | -$112.77M 10-Q · filed 2017-05-15 |
| 2016-12-31 | -$101.26M 10-K · filed 2018-03-12 |
| 2016-09-30 | -$90.29M 10-Q · filed 2016-11-14 |
| 2016-06-30 | -$76.12M 10-Q · filed 2016-08-15 |
| 2015-12-31 | -$53.51M 10-K · filed 2017-03-20 |